Clinical and Psychological Factors to Consider in Achieving Treatment-Free Remission in Patients With Chronic Myeloid Leukemia

Treatment of chronic myeloid leukemia (CML) has evolved dramatically in recent years. In this regard, the introduction of second-generation tyrosine kinase inhibitors (TKI) has revolutionized therapeutic goals, and it is now desirable to obtain treatment-free remission (TFR), i.e. when a patient who...

Descripción completa

Detalles Bibliográficos
Autores principales: Breccia, Massimo, Abruzzese, Elisabetta, Annunziata, Mario, Luciano, Luigia, Sica, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987948/
https://www.ncbi.nlm.nih.gov/pubmed/33777785
http://dx.doi.org/10.3389/fonc.2021.631570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987948/
https://www.ncbi.nlm.nih.gov/pubmed/33777785
http://dx.doi.org/10.3389/fonc.2021.631570

Ejemplares similares